Skip to main content

Table 4 Comparison of the FVC improvement

From: Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China

Improvement of FVC% predicted value (%)

EJ (+)

(5.5 ± 3.8)

JO-1 (+)

(8.6 ± 4.4)

PL-7 (+)

(1.1 ± 0.7)

PL-12 (+)

(2.3 ± 1.8)

OJ (+)

(2.7 ± 1.6)

JO-1 (+)

0.966

–

–

–

–

PL-7 (+)

< 0.001

< 0.001

–

–

–

PL-12 (+)

0.001

< 0.001

0.008

–

–

OJ (+)

0.005

0.004

0.006

0.527

–